{"id":7496,"date":"2026-05-10T15:19:59","date_gmt":"2026-05-10T13:19:59","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=7496"},"modified":"2026-06-01T13:56:08","modified_gmt":"2026-06-01T11:56:08","slug":"ctni","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/ctni\/","title":{"rendered":"\u5fc3\u808c\u808c\u9499\u86cb\u767d I (cTnI)"},"content":{"rendered":"\t\t
PDB ID: 1J1E. Source: RCSB Protein Data Bank. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
The VeriLumenTM<\/sup>\u00a0cTnI Rapid Test is a fluorescence immunochromatographic assay intended for the quantitative measurement of cardiac troponin I (cTnI) concentration in human whole blood, plasma, or serum. Cardiac troponin I is a highly specific biomarker of myocardial injury and is widely used in the clinical assessment of patients with suspected acute myocardial infarction (AMI). The assay provides rapid and sensitive quantitative results to support timely evaluation in laboratory and point-of-care settings.<\/p> This test is mainly used as an aid in the clinical assessment and auxiliary diagnosis of myocardial infarction, supporting healthcare professionals in evaluating patients presenting with chest pain and other symptoms suggestive of acute coronary syndromes. Quantitative cTnI measurement may also assist in monitoring cardiac injury progression when interpreted together with clinical findings and other diagnostic information.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t